By Mill Chart
Last update: Mar 5, 2024
Our stock screening tool has identified GILEAD SCIENCES INC (NASDAQ:GILD) as a strong dividend contender with robust fundamentals. NASDAQ:GILD exhibits commendable financial health and profitability, all while offering a sustainable dividend. Let's delve into each aspect below.
ChartMill provides a Dividend Rating for every stock, ranging from 0 to 10. This rating assesses various dividend aspects, including yield, growth, and sustainability. NASDAQ:GILD earns a 7 out of 10:
ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NASDAQ:GILD, the assigned 5 reflects its health status:
ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:GILD scores a 7 out of 10:
Our Best Dividend screener lists more Best Dividend stocks and is updated daily.
Our latest full fundamental report of GILD contains the most current fundamental analsysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
GILEAD SCIENCES INC
NASDAQ:GILD (4/22/2024, 7:04:09 PM)
After market: 66.95 0 (0%)66.95
+0.19 (+0.28%)
Three of Wall Street's undervalued stocks could provide a unique blend of stability and long-term growth potential.
Gilead Sciences (GILD) closed the most recent trading day at $66.76, moving +0.91% from the previous trading session.
Gilead Sciences (GILD) closed at $66.16 in the latest trading session, marking a -1.15% move from the prior day.
Gilead (GILD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Uncovering Dividend Opportunities with GILEAD SCIENCES INC (NASDAQ:GILD).
Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?
Dividend stocks can be a smart way to ride out market volatility.
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END
/PRNewswire/ -- USA News Group – The American Cancer Society is projecting 2024 to be the first year ever for the US to have more than 2 million new cases,...